Respiratory mucosal vaccination of peptide-poloxamine-DNA nanoparticles provides complete protection against lethal SARS-CoV-2 challengeSi Sun, Shan Guan, Entao Li et al.|Biomaterials|2022Cited by 24
Ebola virus VP35 perturbs type I interferon signaling to facilitate viral replicationZengguo Cao, Sandra Chiu, Cheng‐Yuan Peng et al.|Virologica Sinica|2023Cited by 20
An inoculation site-retained mRNA vaccine induces robust immune responses against SARS-CoV-2 variantsLei Huang, Haifa Shen, Hanfei Zhu et al.|Journal of Controlled Release|2024Cited by 20
An engineered bispecific nanobody in tetrameric secretory IgA format confers broad neutralization against SARS-CoV-1&2 and most variantsWeihong Zeng, Tengchuan Jin, Xiaoying Jia et al.|International Journal of Biological Macromolecules|2023Cited by 12